Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents

PLoS Pathogens - United States
doi 10.1371/journal.ppat.1004128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Prevalence of Resistance-Associated Substitutions to Direct-Acting Antiviral Agents in Hemodialysis and Renal Transplant Patients Infected With Hepatitis C Virus

Infection and Drug Resistance
Infectious DiseasesPharmacology
2018English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Two Cases of Hepatocellular Carcinoma Occurring Immediately After Direct-Acting Antiviral Agents Against Hepatitis C Virus

Internal Medicine
Internal MedicineMedicine
2019English

Concerns About Direct-Acting Antiviral Agents for Hepatitis C—Cause for Reassurance

JAMA network open
Medicine
2019English

Hepatitis C Virus Resistance to Antiviral Therapy

Hepatology
MedicineHepatology
2000English

Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy